Journal of Inflammation Research, 2023 · DOI: https://doi.org/10.2147/JIR.S428425 · Published: October 20, 2023
Spinal cord injury (SCI) is a devastating condition with limited effective treatments. After SCI, secondary injuries create an unfavorable environment for neural recovery, leading to cell death. Mesenchymal stem cell (MSC) transplantation has emerged as a promising therapy. MSCs can promote spinal cord injury repair through mechanisms like immunomodulation, neuroprotection, and nerve regeneration, offering hope for patients. This paper discusses the neuroprotection and nerve regeneration aspects of MSCs for treating spinal cord injuries. MSCs are pluripotent stem cells that can be derived from various tissues. These qualities have caused MSCs to gradually gain attention in the fields of medicine and tissue engineering in recent decades.
MSC transplantation holds therapeutic promise for spinal cord injury due to its neuroprotective and regenerative capabilities.
The need to fully understand therapeutic mechanisms and the optimal methods of MSC transplantation highlights a need for translational research.
Continued research into MSC transplantation may result in more effective clinical applications for spinal cord injury treatment.